News | Cardiac Diagnostics | January 19, 2016

Preliminary Results Published of Largest-Ever Study Linking Biomarkers with Coronary Artery Disease

Study demonstrates proof of concept of causal machine learning approach with identification of known coronary disease-associated pathway

January 19, 2016 — Global Genomics Group (G3) and GNS Healthcare (GNS), announced preliminary results of the GLOBAL Clinical Study designed to identify biomarkers associated with coronary artery disease (CAD). The study provided proof of concept of the approach by prospectively identifying a biochemical pathway known to be associated with CAD.

G3 is a life sciences company that leverages large-scale genomic and molecular disease profiles to develop new diagnostics and therapeutics. GNS is a precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways.

The GLOBAL Clinical Study is the first large-scale study that leverages pan-omic measurements — including whole genome sequencing, whole genome methylation, whole transcriptome sequencing, unbiased proteomics, metabolomics, lipidomics and lipoprotein proteomics — in a specific clinically-relevant patient population – patients referred for coronary computed tomography (CT) angiography for assessment of suspected CAD – with matched normal controls. Subjects from both groups were phenotyped by G3’s advanced, proprietary imaging methods.

The companies utilized the patented GNS REFS (Reverse Engineering and Forward Simulation) platform, which applies advanced machine learning Bayesian reconstruction algorithms, a form of artificial intelligence that extracts cause and effect mechanisms, to rapidly analyze comprehensive pan-omic measurements in order to learn the causal genetic, molecular and phenotypic networks driving atherosclerotic CAD. The approach is designed to enable rapid insights and discoveries that otherwise would not have been possible with current technology. The preliminary results reported here are based on trillions of data points analyzed from G3’s G3LOBAL Database.

Output from the machine learning technology consists of associations of biomarkers with CAD. GNS’s causal machine learning technology provided validation of the approach by identifying the low-density lipoprotein (LDL) disease pathway as associated with CAD, including mechanisms linked to new treatments, such as those targeting the PCSK9 gene. This pathway, identified by more traditional biochemical and cell biology approaches, is well known to cardiologists and a number of drugs that interact with it are approved for lowering the risk of CAD.

The causal, mechanistic computer models may greatly accelerate the pace of discovery. The recapitulation of known LDL biology and discovery of new biology announced, for instance, were achieved by G3 and GNS in less than a year. In contrast, the original discovery of LDL biology can be traced to a series of discoveries, beginning as early as 1938, accelerating in the 1970s, and earning the Nobel Prize in Physiology or Medicine in 1985 for the identification of the LDL receptor.

For more information:,

Related Content

Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics | December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics | December 07, 2017
December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging.
E-cigarettes Most Likely to be Used by Alcohol Drinkers and Former Cigarette Smokers, at American Heart Association (AHA), #AHA2017.
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol dri
Lack of sleep may cause heart disease in older women. American heart Association, #AHA2017
News | Cardiac Diagnostics | December 06, 2017
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health, accor
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics | December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

The EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

News | Cardiac Diagnostics | November 24, 2017
November 24, 2017 — Any physical activity in the elderly is better than none at all for reducing cardiovascular risk,
Analytics 4 Life Presents Clinical Data on Machine-Learned Cardiac Imaging Technology at TCT 2017
News | Cardiac Diagnostics | November 01, 2017
Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary Artery Disease...
American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics | October 20, 2017
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation...
Overlay Init